Loading provider…
Loading provider…
Hematology & Oncology Physician in Montvale, NJ
NPI: 1396159703Primary Employer
Msk Bergen
mskcc.org
HQ Phone
Get M.D. Ritesh's Phone Numberphone_androidMobile
Get M.D. Ritesh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2021
NJ State Medical License
2020 - 2027
NY State Medical License
2017 - 2026
PA State Medical License
2023 - 2026
MA State Medical License
2014 - 2017

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
2017 - 2020
Beth Israel Deaconess Medical Center
Residency • Internal Medicine
2014 - 2017
Albany Medical College
amc.edu
Medical School
Until 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 119 | 362 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 50 | 68 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 30 | 30 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 25 | 31 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 14 | 51 |
Authors: Kyrollis Attalla, Abraham Hakimi, Roy Mano, Martin Voss, Robert Motzer, Arturo Holmes, Paul Russo, Jonathan Coleman
Journal: Cancer
Publication Date: 2021-07-19
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
Authors: Kelly Fitzgerald, Neil Shah, Abraham Hakimi, Darren Feldman, Martin Voss, Robert Motzer, Maria Carlo
Journal: Cancer
Publication Date: 2023-10-21
Regression of Intracranial Meningiomas Following Treatment with Cabozantinib.
Authors: Yazmin Odia, Rupesh Kotecha, Guilherme Rabinowits, Minesh Mehta
Journal: Curr Oncol
Publication Date: 2021-04-18
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Exelixis
Intervention / Treatment: DRUG: Cabozantinib, RADIATION: Stereotactic Radiosurgery (SRS), DEVICE: Nivolumab
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Intervention / Treatment: DRUG: Axitinib, DRUG: Talazoparib
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Intervention / Treatment: DRUG: Avelumab, DRUG: Talazoparib